BAJAJHCARENSEBajaj Healthcare Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 5 Jun, 2025 · 16:45 IST

Bajaj Healthcare Limited has informed the Exchange regarding Resignation of Mr. Dhananjay Sabaji Hatle as Executive Director of the company w.e.f. Jun 05, 2025.

Kmp ResignedManagement Changes View source PDFExplain this filing

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.8%Reaction day
₹538.80
prior close
₹536.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.7% vs market
Pharmaceuticals peers, median of 151sector-0.3%-1.5% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-1.2
15m
-1.2
30m
-1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.8-0.1-1.7-0.3-1.5
Next day
-1.3+1.3-2.6+0.4-1.7
2d
-1.6+2.1-3.7+0.8-2.4
3d
-2.7+2.5-5.2+1.7-4.5
4d
-2.2+1.0-3.2+1.5-3.6
5d
-4.1+0.6-4.8+1.1-5.2
1w
-0.9-0.1-0.8-0.7-0.2
15d
-3.5+1.3-4.8-0.6-2.9
1m
-12.5+2.1-14.6+0.7-13.3
2m
-15.6-1.4-14.1-2.6-13.0
3m
-20.8-0.1-20.7-3.3-17.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Dhananjay Sabaji Hatle (DIN: 00226390) has resigned as Whole-Time Director of Bajaj Healthcare Limited with immediate effect from June 5, 2025. He cited personal reasons for his exit and confirmed there are no other material reasons behind the decision. The company filed the intimation with the stock exchanges under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). This is a single director exit and no governance, audit, or performance concerns were flagged in the filing. No successor or interim arrangement has been announced in this disclosure.

Likely market impact

The departure of a Whole-Time Director citing personal reasons is a routine board-level change with limited immediate impact on operations. Shareholders should watch for a follow-up announcement on board reconstitution or any successor appointment.